Psychiatry & Neurology Doctors in Leander, TX Accepting Medicare

2 Psychiatry & Neurology doctors found. Showing 1 - 2

Jigar Patel, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 15141 Ronald Reagan Blvd, Unit # 509, Leander, TX 78641 Phone: 512-522-8812    Fax: 512-638-8812

Dr. Kathryn J Kotrla, M.D. Psychiatry & Neurology - Behavioral Neurology & Neuropsychiatry Medicare: Not Enrolled in Medicare Practice Location: 22974 Nameless Rd, Leander, TX 78641 Phone: 512-267-1894

News Archive

A few clinics are focused on helping pregnant women with prescription drug addictions

The Wall Street Journal examines the growing number of women addicted to pain killers and efforts to help them through pregnancies.

FDA grants accelerated approval to ARIAD's Iclusig for treatment of CML, Ph+ ALL

ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.

Study: Only half of Americans with a history of heart disease get annual flu shot

People with heart disease are more likely to become seriously ill from the flu and other respiratory illnesses, including the coronavirus.

Vitrolife takes over sales and marketing management of fertility media in UK and Ireland

Vitrolife (STO:VITR) is taking over management of marketing and sales of fertility media in UK and Ireland. "The acquisition is in line with Vitrolife's strategy to operate using our own personnel and our own management in the most important markets," says Magnus Nilsson, Vitrolife's CEO.

Enrollment complete in Unigene's oral PTH Phase 2 osteoporosis study in postmenopausal women

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company has completed patient enrollment of its Phase 2 study with an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.

Read more Medical News

› Verified 3 days ago